Company / Operating Income per Share
Medpace Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
$17.46
FY2025
5-year range
$4.64 / $17.46
FY2021-FY2025
Trend
+20.2%
vs FY2024
Sector context
#11 of 154
Health Care
What the data says
Among 154 Health Care companies, Medpace is in the top 7% for operating income per share. Operating Income per Share has increased for 3 consecutive years, from $4.64 in FY2022 to $17.46 in FY2025.
Based on SEC 10-K filings.
17.46 in FY2025 with a 5-year CAGR of +30.4%. Top quartile in the Health Care sector.
Improved from $10.83 to $17.46 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- +55.6%
- 5-Year CAGR
- +30.4%
- 10-Year CAGR
- -
Sector benchmark
+310.5% above sector average
Key checks
Key Insights
- Medpace's operating income per share has grown for 3 consecutive years.
- In FY2025, operating income per share increased 20.2% year-over-year.
- Ranks #11 out of 154 companies in the Health Care sector.
- Lowest operating income per share in the period was in FY2018.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
- Strong return on equity: 147.5%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $17.46 | +20.2% |
| FY2024 | $14.53 | +34.1% |
| FY2023 | $10.83 | +133.5% |
| FY2022 | $4.64 | -17.0% |
| FY2021 | $5.59 | +20.7% |
| FY2020 | $4.63 | +29.8% |
| FY2019 | $3.57 | +141.1% |
| FY2018 | $1.48 | -7.2% |
| FY2017 | $1.60 | -0.9% |
| FY2016 | $1.61 | +145.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026